Free Cash Flow Build Up

Orphazyme A/S (ORPH)

$ 17.1783
7.1283 (+70.93%)
Year
A/P
2015
Projected
2016
Projected
2017
Projected
2018
Projected
2019
Projected
2020
Projected
2021
Projected
2022
Projected
2023
Projected
2024
Projected
2025
Projected
Revenue -----------
EBITDA -----------
EBIT -----------
Tax Rate 10.65%8.67%4.18%2.34%1.60%0.30%4.62%4.62%4.62%4.62%4.62%
EBIAT -----------
Depreciation -----------
Accounts Receivable -----------
Inventories -----------
Accounts Payable -----------
Capital Expenditure -0.49-0.24-1.49-2.35-3.29-5.10-----
UFCF -----------
WACC
PV UFCF -----------
SUM PV UFCF -